FR3088824B1 - Fucanes sulfates de bas poids moleculaire dans les dermatoses inflammatoires - Google Patents

Fucanes sulfates de bas poids moleculaire dans les dermatoses inflammatoires Download PDF

Info

Publication number
FR3088824B1
FR3088824B1 FR1872020A FR1872020A FR3088824B1 FR 3088824 B1 FR3088824 B1 FR 3088824B1 FR 1872020 A FR1872020 A FR 1872020A FR 1872020 A FR1872020 A FR 1872020A FR 3088824 B1 FR3088824 B1 FR 3088824B1
Authority
FR
France
Prior art keywords
molecular weight
low molecular
fucanes
sulphates
inflammatory dermatoses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1872020A
Other languages
English (en)
Other versions
FR3088824A1 (fr
Inventor
Marie Françoise Aries
Stéphane Poigny
Hélène Hernandez-Pigeon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Priority to FR1872020A priority Critical patent/FR3088824B1/fr
Priority to PCT/EP2019/082861 priority patent/WO2020109445A1/fr
Publication of FR3088824A1 publication Critical patent/FR3088824A1/fr
Application granted granted Critical
Publication of FR3088824B1 publication Critical patent/FR3088824B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne l’utilisation d’un fucane sulfaté de bas poids moléculaire (1-25kDa), ainsi que d’une composition dermatologique ou dermo-cosmétique contenant un tel fucane, dans le traitement et/ou la prévention de dermatoses inflammatoires, notamment la dermatite atopique.
FR1872020A 2018-11-28 2018-11-28 Fucanes sulfates de bas poids moleculaire dans les dermatoses inflammatoires Expired - Fee Related FR3088824B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1872020A FR3088824B1 (fr) 2018-11-28 2018-11-28 Fucanes sulfates de bas poids moleculaire dans les dermatoses inflammatoires
PCT/EP2019/082861 WO2020109445A1 (fr) 2018-11-28 2019-11-28 Fucanes sulfates de bas poids moleculaire dans le traitement de la dermatite atopique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1872020A FR3088824B1 (fr) 2018-11-28 2018-11-28 Fucanes sulfates de bas poids moleculaire dans les dermatoses inflammatoires

Publications (2)

Publication Number Publication Date
FR3088824A1 FR3088824A1 (fr) 2020-05-29
FR3088824B1 true FR3088824B1 (fr) 2021-01-15

Family

ID=66542321

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1872020A Expired - Fee Related FR3088824B1 (fr) 2018-11-28 2018-11-28 Fucanes sulfates de bas poids moleculaire dans les dermatoses inflammatoires

Country Status (2)

Country Link
FR (1) FR3088824B1 (fr)
WO (1) WO2020109445A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8426381B2 (en) * 2005-09-09 2013-04-23 Lucas Meyer Cosmetics Canada Inc. Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
WO2010086696A1 (fr) 2009-01-28 2010-08-05 Therapol Polysaccharides sulfatés de faible masse moléculaire comme candidats pour une thérapie anti-angiogénique

Also Published As

Publication number Publication date
WO2020109445A1 (fr) 2020-06-04
FR3088824A1 (fr) 2020-05-29

Similar Documents

Publication Publication Date Title
MA42279B1 (fr) Compositions comprenant une souche bactérienne de blautia hydrogenotrophica pour l'utilisation pour la prevention ou le traitement de la diarrhee ou la constipation
MA46990B1 (fr) Compositions glp-1 et ses utilisations
MX2020002869A (es) Compuestos de pirazolopirimidinona y usos de los mismos.
FR3044900B1 (fr) Agents nettoyants tensioactifs comportant au moins trois agents conservateurs differents
MA41060B1 (fr) Compositions comprenant des souches bactériennes
MA55434A (fr) Compositions comprenant des souches bactériennes
MX2021014709A (es) Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes.
MA38567A1 (fr) Variantes de pertuzumab et leur évaluation
MA41010A (fr) Compositions comprenant des souches bactériennes
MA39767B1 (fr) Solution aqueuse ophtalmique et méthode de traitement du syndrome de l'œil sec
FR3028753B1 (fr) Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
BR112014015909A2 (pt) composição
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
MX2019008434A (es) Muteínas de lipocalina con afinidad de unión por lag-3.
FR3052977B1 (fr) Composition comprenant au moins un polymere acrylate et au moins une silicone choisie parmi les silicones fonctionalisees par au moins un groupement mercapto ou thiol
EA202190073A1 (ru) Композиции и способы лечения видов гемоглобинопатии и талассемии
CO2021004141A2 (es) Moduladores de la expresión de pnpla3
FR3017291B1 (fr) Billes de cellulose exfoliantes et utilisations cosmetiques de celles-ci
FR3065644B1 (fr) Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation
AR084583A1 (es) Sistemas de polimeros
TR201902741T4 (tr) Kişisel Temizlik Bileşimleri
MX2022008659A (es) Moléculas de anticuerpos específicos contra c5ar1 y usos de estas.
CL2020003010A1 (es) Moduladores de la expresión de apol1
MA38369A1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
NZ710337A (en) Compositions containing chondroitin sulphate, proteolytic enzymes and sulphydryl compounds for improving the bioavailability of chondroitin sulphate

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200529

PLFP Fee payment

Year of fee payment: 3

ST Notification of lapse

Effective date: 20220705